Table 5

Results of multivariable analysis for predictors of overall mortality

VariablesN1/N2RR (95% CI)P
Conditioning regimen   < .001* 
    FLU-containing regimen 21/46 1.00  
    Non–FLU-containing regimen, T-cell–depleted grafts 24/26 3.44 (1.72-6.91) < .001 
    Non–FLU-containing regimen, non–T-cell-depleted grafts 19/24 3.57 (1.80-7.06) < .001 
Prior red blood cell transfusions    
    20 or less 26/40 1.00  
    More than 20 22/24 2.49 (1.34-4.66) .004 
Donor-recipient CMV status   .007 
    Donor negative/recipient negative 30/45 1.00  
    Donor positive/recipient negative 11/18 1.09 (0.53-2.26) .817 
    Donor negative/recipient positive 15/24 1.29 (0.68-2.44) .437 
    Donor positive/recipient positive 8/9 4.52 (1.90-10.74) < .001 
VariablesN1/N2RR (95% CI)P
Conditioning regimen   < .001* 
    FLU-containing regimen 21/46 1.00  
    Non–FLU-containing regimen, T-cell–depleted grafts 24/26 3.44 (1.72-6.91) < .001 
    Non–FLU-containing regimen, non–T-cell-depleted grafts 19/24 3.57 (1.80-7.06) < .001 
Prior red blood cell transfusions    
    20 or less 26/40 1.00  
    More than 20 22/24 2.49 (1.34-4.66) .004 
Donor-recipient CMV status   .007 
    Donor negative/recipient negative 30/45 1.00  
    Donor positive/recipient negative 11/18 1.09 (0.53-2.26) .817 
    Donor negative/recipient positive 15/24 1.29 (0.68-2.44) .437 
    Donor positive/recipient positive 8/9 4.52 (1.90-10.74) < .001 

N1 indicates number of deaths; N2, number of evaluable patients; and FLU, fludarabine.

*

Two-degree freedom test.

Three-degree freedom test.

Close Modal

or Create an Account

Close Modal
Close Modal